Jeremy Graff
Chief Tech/Sci/R&D Officer at IMV INC.
Net worth: 4 731 $ as of 2024-04-29
Network origin in Jeremy Graff first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
23
| Public Company | Biotechnology | 23 |
14
| Public Company | Biotechnology | 14 |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN.
12
| Private Company | Miscellaneous Commercial Services | 12 |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.
7
| Subsidiary | Medical/Nursing Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeremy Graff via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal General Counsel | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Director/Board Member | |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
Vium, Inc.
 Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| University of Connecticut | College/University | Doctorate Degree Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
| Université Laval | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
PlaqueTec Ltd.
 PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
COMPASS Pathfinder Holdings Ltd.
 COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member | |
| The European Commission | General Government | Corporate Officer/Principal | |
CellMedical SA
 CellMedical SA Medical/Nursing ServicesHealth Services CellMedical SA operates medical diagnostic laboratories. The company is headquartered in Thessaloniki, Greece. | Medical/Nursing Services | Chairman | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
PhESi LLC
 PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
Thrombolytic Science International LLC
 Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
| Phaim Pharma Ltd. | Director/Board Member | ||
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Conduit Connect Ltd.
 The Conduit Connect Ltd. Internet Software/ServicesTechnology Services The Conduit Connect Ltd. is a private membership platform for high net worth, sophisticated, and professional impact investors. The company is based in London, UK. The British company connects founders who are building scalable, for-profit, impact-driven businesses to capital and expert resources. The company source and connects the most promising high growth impact investing opportunities to mission-aligned investors. The company was founded in 2018, and the CEO is Eva-Maria Dimitriadis. | Internet Software/Services | Chairman |
Statistics
International
| United States | 28 |
| United Kingdom | 14 |
| Canada | 5 |
| Germany | 3 |
| France | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 8 |
| Health Services | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 211 |
| Corporate Officer/Principal | 109 |
| Independent Dir/Board Member | 52 |
| Chairman | 40 |
| Chief Executive Officer | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Luba Greenwood | 32 |
| Michael Grey | 32 |
| Brent Ahrens | 30 |
| Julia Gregory | 22 |
| Alan Roemer | 21 |
| Pierre Labbé | 19 |
| Alexander R. Giaquinto | 19 |
| Walter Ogier | 18 |
| Shermaine Tilley | 17 |
| Andrew LaFrence | 16 |
| James Hall | 16 |
| Barry A. Labinger | 12 |
| Tracy Sherren | 11 |
| Markus Warmuth | 11 |
- Stock Market
- Insiders
- Jeremy Graff
- Company connections
